Central sympathetic blockade ameliorates brain death-induced cardiotoxicity and associated changes in myocardial gene expression  by Yeh, Thomas et al.
Central sympathetic blockade ameliorates brain death–
induced cardiotoxicity and associated changes in
myocardial gene expression
Thomas Yeh, Jr, MD, PhDa
Andrew S. Wechsler, MDc
Laura Graham, LVTe
Kathryn E. Loesser, PhDd
Domenic A. Sica, MDf
Luke Wolfe, MSe
Emma R. Jakoi, PhDb
Objective: Brain death results in cardiac injury and hemodynamic instability. After
brain death, catecholamine levels surge in concert with increased expression of
select myocardial gene products. Sympathetic blockade was used to investigate the
effects of the adrenergic nervous system on myocardial gene expression in a rabbit
model of brain death.
Methods: A balloon expansion model of brain death in rabbits (n  42) was used
with and without sympathetic blockade (xylazine, acetylpromazine, and ketamine).
Sham-operated and naive rabbits served as control animals. Over 4 hours, mean
arterial pressure, heart rate, electrocardiographic results, catecholamine levels, myo-
cardial histology, and messenger RNA levels were assessed.
Results: Sympathetic blockade decreased basal catecholamine levels and blocked
the catecholamine surge accompanying brain death. The typical hemodynamic
instability, adverse electrocardiographic changes, and myocellular injury associated
with brain death were all significantly decreased. Sympathetic blockade not only
suppressed the previously reported increases in myocardial gene expression (cardiac
and skeletal -actin, egr-1, and heat shock protein 70) but also suppressed the
expression of multiple other genes ( and  myosin heavy chain, calcium ATPase
[sarcoplasmic reticulum Ca2–adenosine triphosphatase pump, SERCA-2a], phos-
pholamban [ryanodine receptor], and c-jun).
Conclusion: Central sympathetic blockade minimizes the hemodynamic instability
associated with brain death and neutralizes the increased expression of multiple
myocardial gene products associated with brain death.
Acute brain death caused by increased intracranial pressure (ICP) isassociated with myocardial dysfunction and injury.1 As a result,40% of potential donor hearts cannot be used.2 A subset of donorhearts that are accepted for donation will ultimately manifest earlygraft failure from the same phenomenon. Although the underlyingmolecular mechanisms remain undefined, the sympathetic ner-
vous system has long been implicated in these changes.
After brain death, interstitial3 and systemic1 catecholamines are rapidly and
markedly increased and then go on to decrease to levels below baseline. Fluctuations
in catecholamine levels might act as important signals in the subsequent alterations
in myocardial gene expression,1 specifically increases in cardiac and skeletal -ac-
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tin, egr-1, and heat shock protein 70 (hsp70). Cat-
echolamines affect myocardial gene expression in cultured
myocytes4-7 and in clinical scenarios of congestive heart
failure8,9 and pheochromocytoma.10 In models of chronic
catecholamine increase, decreased expression of mRNAs
encoding sarcoplasmic reticulum proteins (calcium adeno-
sine triphosphatase [ATPase], phospholamban, and calcium
release channel) and myofibrillar proteins ( myosin heavy
chain and -actin) is found, as is increased expression of
atrial natriuretic factor messenger RNA.11 Increased levels
of norepinephrine have also been shown to stimulate apo-
ptosis.12 In contrast, physiologic catecholamine release can
initiate a growth (hypertrophic) response, including in-
creased expression of mRNAs for myofibrillar proteins4,13,14
and transcription factors.15
The onset of cardiac dysfunction can be delayed 24 to 48
hours after head injury. This delay might be the result of a
finite period of time required for changes in myocardial
gene expression to be functionally manifest as decreased
organ function. Earlier work supports this hypothesis,
wherein brain death lead to increased expression of stress-
related and myofibrillar genes in a pattern that was similar
to that for cardiac hypertrophy.1 In the current study phar-
macologic blockade of the central sympathetic nervous sys-
tem was used to test the hypothesis that sympathetic block-
ade would protect the heart during head injury and that this
protection would prevent the increases in gene expression
previously observed.1
Methods
Anesthetic Regimens
All experimental animals received humane care in compliance
with the “Principles of Laboratory Animal Care” (National Society
for Medical Research) and the “Guide for Care and Use of Lab-
oratory Animals” (prepared by the Institute of Laboratory Animal
Resources, National Research Council, and published by the Na-
tional Academy Press, revised 1996). To minimize stress, animals
were cared for in a controlled environment before experimentation.
New Zealand White rabbits (3.5-4.0 kg) were used. Anesthesia
was induced with fentanyl (0.1 mg/kg administered intramuscu-
larly) and maintained with inhaled isoflurane (3% on induction and
1.5% after induction).
Surgical Model
A total of 42 New Zealand White rabbits were used. Surgical
instrumentation was performed as previously described.1 After
tracheostomy, ventilator adjustments were based on serial arterial
blood gas measurements. Pulse and blood pressure from a carotid
arterial line were recorded at baseline and at timed intervals over
4 hours. Electrocardiographic (ECG) recordings were taken before
and after brain death. Rabbits were randomly assigned to the
groups outlined in Table 1.
Results from the ICP and sham groups were previously pub-
lished1 and are included here to facilitate comparisons. The current
data were generated concurrently with the previously published
data. Central sympathetic blockade (CSB) was achieved with 3
agents: xylazine, an 2-adrenergic agonist that blocks central sym-
pathetic outflow16; acetylpromazine, which blocks peripheral 1-
adrenergic receptors and central dopaminergic receptors17; and
TABLE 1. Experimental groups
Group
abbreviation Group description
No. of
animals
ICP-CSB Brain death (increased intracranial pressure) with central sympathetic blockade n 9
Sham-CSB Sham-operated control animals with central sympathetic blockade n 9
ICP Brain death (increased intracranial-pressure) without central sympathetic blockade (previously published)1 n 9
Sham Sham-operated control animals without central sympathetic-blockade (previously published)1 n 9
Naive Unoperated controls animals used to establish baseline references at time 0 n 6
TABLE 2. Quantitative scoring of left ventricular histologic injury
Histologic parameter
No CSB Other comparisons CSB Other comparisons
Sham (1) ICP (2) (1) vs (3) Sham (3) ICP (4) (2) vs (4)
Chromatin clumping 0.000 0.000 0.108 0.054* 0.000 0.000 0.000 0.000 *
Contraction banding 0.070 0.027 0.354 0.067* * 0.136 0.047 0.058 0.025* *
Cytoplasmic clearing 0.837 0.062 1.369 0.060* * 0.375 0.059 0.267 0.051* *
Loss of striations 1.131 0.068 1.582 0.055* * 0.378 0.060 0.907 0.048* 0
Four groups were examined: increased ICP and sham-operated (control) hearts in the absence of CSB (columns labeled 1 and 2, data previously reported)
and in the presence of CSB (sham [column 3] and ICP-CSB [column 4]). Specimens were graded on a scale from 0 (no injury) to 2 (diffuse injury). Three
sections from each animal were divided into 8 regions, resulting in 24 samplings from each animal. The increased ICP-CSB group shows some histologic
injury when compared with sham-operated CSB animals but considerably less than in unattenuated animals with ICP. However, CSB abrogated much of
the ICP-induced damage by all tested parameters. Data are reported as means  SEM.
*Significant differences between groups was determined by using analysis of variance, P  .05.
Cardiopulmonary Support and Physiology Yeh et al
1088 The Journal of Thoracic and Cardiovascular Surgery ● December 2002
CSP
ketamine, an N-methyl-D-aspartate agonist that decreases plasma
epinephrine and norepinephrine levels.18
After anesthesia was induced, a 5-mm burr hole was placed in
the right parietal calvarium and an 8F balloon-tipped catheter was
inserted between the dura and calvarium. The balloon was rapidly
inflated with 3 mL of saline solution to increase ICP (t 0). Brain
death occurred within 5 minutes of balloon inflation, as determined
by means of electroencephalography. All operated groups were
killed at 1, 2, and 4 hours. Naive rabbits (n 6) were killed at time
0 to establish baseline controls. Hearts were rapidly excised and
rinsed with cold heparinized saline solution, and the right and left
ventricles were dissected. Myocardial tissue was frozen in liquid
nitrogen and stored at 70°C.
Histologic Evaluation
Separate groups of operated hearts (ICP, ICP-CSB, sham-operated,
and sham-operated CSB groups) were evaluated for cellular dam-
age, as previously described.1 Ventricular tissue was divided into
cross-sections (2 mm) and postfixed in 3% glutaraldehyde and
1.5% paraformaldehyde for 1 hour (21°C) and then overnight
(4°C). Specimens were dehydrated, embedded in paraffin blocks,
and sectioned. Three 7-m sections (taken from separate blocks)
were stained with hematoxylin and eosin.
Sections were scored by a cardiac pathologist blinded to the
experimental group by using a glass template to identify 8 regions
per section. Each region was evaluated for 4 characteristics: con-
traction banding, myocytolysis, pyknotic nuclei, and loss of myo-
fibrillar striations. A score of 0 indicated no damage. A score of 2.0
indicated widespread lesions. Intermediate lesions received scores
ranging from 0.5 to 1.5.
RNA Analysis
Total RNA was isolated by using a guanidinium isothiocyanate/
CsCl.19 The integrity of mRNA and appropriate hybridization and
wash stringencies were confirmed by means of Northern blot
analyses, as previously described.1 Slot-blot hybridization was
used to quantitate levels of specific mRNAs. Four micrograms of
total RNA from each specimen was immobilized on a nitrocellu-
lose membrane. Membranes were prehybridized (42°C overnight)
in hybridization buffer (4 standard saline citrate solution, 50
mmol/L NaH2PO4, 0.2% sodium dodecylsulfate, 5 Denhardt’s
solution, 200 mg/mL tRNA, and 50% formamide) and then se-
quentially hybridized with a series of specific complementary
phosphorus 32–labeled probes. Between probings, membranes
were stripped (80°C for 2 minutes) and exposed to film overnight
to verify the absence of signal.
Oligonucleotide probes were radiolabeled with T4 polynucle-
otide kinase reaction. Complementary DNA probes were radiola-
beled with random primers and Klenow polymerase. Total
poly(A)RNA was estimated by hybridization with poly d(T)
probe (BD Biosciences Clontech, Palo Alto, Calif).
Densitometry and Data Standardization
Hybridization signals were quantitated by means of densitometric
scanning of autoradiograms exposed within the linear range of the
x-ray film. Integrated densities of each specimen were calculated
with the GELScan 1D analysis program (Pharmacia LKB, Pisca-
taway, NJ). The optical density was normalized to that of
poly(A)RNA to adjust for variations in loading and transfer. The
mean of this ratio was then divided by the mean of naive hearts
(t  0) and plotted against time. Data are reported as means 
SEM.
Quantitation of Systemic Catecholamines
Plasma epinephrine and norepinephrine levels were measured be-
fore and serially after balloon inflation, as previously described.1
Levels were determined with an ESA Coulochem II Electrochem-
ical Detector; ESA, Inc, Chelmsford, Mass). Plasma cat-
echolamines were extracted with aluminum oxide and separated by
means of high-pressure liquid chromatography with an isocratic
mobile phase (85% NaH2PO4 and 15% acetonitrile, adjusted to pH
3.0 with H3PO4). Run time was 28 minutes. The limit of detection
was 10 pg/mL.
Statistical Analyses
Statistical analyses were performed with SAS software (SAS In-
stitute, Inc, Cary, NC). Analysis of variance was used to determine
the significance of change at each time point between groups and
changes over time within each group.
Results
Sympathetic Blockade Improves the Hemodynamic
Instability Associated With Brain Death
In the presence of sympathetic blockade, brain death re-
sulted in a slight but significant increase in heart rate within
30 minutes (Figure 1, A). This relatively small increase in
heart rate gradually settled over 4 hours to a level signifi-
cantly below baseline. This is in distinct contrast to brain
death in the absence of sympathetic blockade (Figure 1, B).
These animals exhibited marked tachycardia 1 to 5 minutes
after brain death. No significant difference in heart rate was
observed in either sham-operated group, although the base-
line heart rate was lower in the sham-operated group with
CSB. Of note, the bradycardia one might expect as part of
the Cushing response is typically present when ICP is
increased more slowly. Tachycardia results in this model
because of the rapidity with which ICP was increased.
In the presence of sympathetic blockade, brain death
resulted in no hypertensive response and less hemodynamic
deterioration by 4 hours (Figure 1, C). Again, in distinct
contrast, unattenuated brain death resulted in a marked
hypertensive response and a significant hypotensive re-
sponse at 30 minutes (Figure 1, D). The sham-operated
control groups showed a slow decline in mean arterial
pressure over time.
Sympathetic Blockade Prevents EGG Changes
Associated With Brain Death
As previously reported,1 after brain death, analysis of ECG
ST segments previously revealed abnormal ST segments
(ST-segment depression, ST-segment elevation, or T-wave
inversion) in all animals undergoing unattenuated increases
in ICP. In contrast, sympathetic blockade preserved normal
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Figure 1. Effects of sympathetic blockade on hemodynamic changes (in heart rate and mean arterial pressure
[MAP]) induced by brain death resulting from increased ICP. Data are reported as means  SEM. Asterisks denote
a significant P value. Table 1 summarizes the experimental groups and legends for these graphs: solid line,
ICP-CSB group; dashed and dotted line, sham-CSB group; dashed line, ICP group; dotted line, sham group. A, Heart
rates during sympathetic blockade (ICP-CSB and sham-CSB groups). Note the relative absence of tachycardia in
either group during sympathetic blockade. Differences between groups are significant (P < .05) at time points 0
and 2 through 4 hours. Within the ICP-CSB group, significant differences from baseline over time were found at time
points 0.08, 0.17, and 0.24 hours. Within the sham-operated group, changes over time were significant at time points
3.00, 3.50, 3.75, and 4.00 hours. B, Heart rates during sympathetic blockade (ICP-CSB and sham-CSB groups, see
above) are compared with heart rates without sympathetic blockade (ICP and sham groups, as previously
reported1). Note the tachycardia induced during brain death without sympathetic blockade (ICP group). Note also
the relatively lower heart rates present in both groups undergoing sympathetic blockade (ICP-CSB and sham-CSB
groups), affirming the adequacy of sympathetic blockade in those animals. Finally, note the similarly low heart rate
achieved after brain death without sympathetic blockade (ICP group). C, Temporal profile of mean arterial pressure
for ICP-CSB and sham-CSB animals. Note the absence of hypertension induced by means of CSB. Differences
between groups are significant (P < .05) at time points 0.25 to 1 hour. Within the ICP-CSB group, significant
difference from baseline over time were found at all time points except 0.02 to 0.17 hours. Within the sham-
operated group, changes over time were significant at all time points from 0.75 to 4.00 hours. D, Comparison of
above data with increases in mean arterial pressures previously reported for increased ICP (ICP group) and
sham-operated animals (sham) without sympathetic blockade. Note that ICP without sympathetic blockade results
in more hemodynamic instability than ICP protected by sympathetic blockade.
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ECG morphology (Figure 2). Sham-operated control ani-
mals were also unchanged over time (2-4 hours).
Sympathetic Blockade Prevents the Catecholamine
Surge Induced by Brain Death
Plasma epinephrine and norepinephrine levels were mea-
sured after brain death with and without sympathetic block-
ade to verify that sympathetic blockade was effective. The
brain dead and sham-operated control groups with sympa-
thetic blockade (ICP-CSB and sham-CSB groups) did not
differ in plasma epinephrine or norepinephrine levels (Fig-
ure 3, A and C, respectively). When sympathetically
blocked animals were compared with sham-operated ani-
mals without sympathetic blockade (Figure 3, B and D,
respectively), catecholamine levels were significantly lower
than baseline levels. Fifteen minutes after balloon inflation,
the ICP-CSB group had similarly low plasma epinephrine
and norepinephrine levels of 13 pg/mL (Figure 3, A) and 56
pg/mL (Figure 3, C), respectively.
In contrast, 15 minutes after balloon inflation, the ICP
group (without sympathetic blockade) showed a 3.5-fold
increase in plasma epinephrine (772 pg/mL; Figure 3, B)
and an 8-fold increase in plasma norepinephrine (3042
pg/mL; Figure 3, D) levels. A significant decline in
plasma catecholamine levels were found 2 to 4 hours
after balloon inflation in the ICP group (Figure 3, B and
D). Plasma catecholamine levels in the sham-operated
(control) group remained unchanged over time (Figure 3,
B and D). This decrease in catecholamine levels in ani-
mals with increased ICP temporally corresponded to a
decline in mean arterial pressure and heart rate. After
unattenuated brain death, catecholamine levels decreased
to levels that were similar to those observed in the
presence of sympathetic blockade.
Sympathetic Blockade Prevents the Histologic Injury
Associated With Brain Death
Sixty minutes after brain death, hearts from 2 rabbits in each
group (ICP-CSB, sham-operated CSP, ICP,1 and sham-
operated1 groups) were fixed, stained, and then graded by a
cardiac pathologist blinded to experimental group. Repre-
sentative sections are shown in Figure 4. Hearts were indi-
vidually graded for changes in 4 parameters by using a score
that ranged from 0 (no injury) to 2 (diffuse injury). As
reported previously,1 the brain death (ICP) group exhibited
significantly more cellular injury, as evidenced by cytoplas-
mic clearing, loss of myofibrillar striations, and contraction
banding; however, no interstitial mononuclear cell infiltra-
tion and few pyknotic nuclei were seen. In contrast, these
experiments reveal that brain death, in the presence of
Figure 2. Effects of CSB on increased ICP-induced changes in electrocardiograms. Sham-operated animals showed
no change before and after intervention. Brain dead animals without CSB (ICP) revealed abnormal ST-segment
morphology that persisted variably over the course of the experiment. Brain dead animals with CSB (ICP-CSB)
revealed no change in ECG morphology before or after brain death.
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sympathetic blockade (Table 2), resulted in significantly
less injury than that seen in the brain dead group (but more
than that seen in the CSB sham-operated group).
Sympathetic Blockade Neutralized the Increases in
Myocardial Gene Expression Induced by Brain Death
Levels of mRNAs encoding myofilament proteins. The
mRNA expression levels of cardiac -actin (Figure 5, A)
and skeletal -actin (Figure 5, B) were assayed in the
ICP-CSB group and compared with that in the ICP group
and that in naive animals. Four hours after balloon inflation,
significant (P  .05) decreases were noted in the ICP-CSB
group. Relative expression levels for these mRNAs de-
creased 2-fold in the ICP-CSB group.
When  myosin heavy chain (MHC; Figure 5, C) and
-MHC (Figure 5, D) mRNA levels were examined, the
Figure 3. Effects of CSB on increased ICP-induced changes in systemic catecholamine (epinephrine and norepi-
nephrine) levels. Data are given as means  SEM. Asterisks denote a significant P value. Table 2 summarizes the
experimental groups and legends for these graphs: solid line, ICP-CSB group; dashed and dotted line, sham-CSB
group; dashed line, ICP group; dotted line, sham group. A, Temporal profile of systemic epinephrine levels for
ICP-CSB and sham-CSB animals. Note the stable and low epinephrine levels induced by means of CSB. Differences
between groups are not significant at any time point. Within the ICP-CSB group, no significant difference from
baseline was noted over time. Within the sham-operated group, changes over time were not significant at any time
point. B, Comparison of above data with increases in systemic epinephrine levels previously reported for ICP and
sham-operated animals without blockade. Note that baseline levels are much lower in animals with sympathetic
blockade. C, Temporal profile of systemic norepinephrine levels for ICP-CSB and sham-CSB animals. Note the
stable and low norepinephrine levels induced by CSB. Differences between groups are not significant at any time
point. Within the ICP-CSB group, no significant difference from baseline was noted over time. Within the
sham-operated group, changes over time were significant at 2 hours. D, Comparison of above data with increases
in systemic norepinephrine levels previously reported for increased ICP and sham-operated animals without
blockade. Note that baseline levels are much lower in animals with sympathetic blockade.
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ICP-CSB group failed to show the significant and sustained
(1-4 hours) increase observed after ICP. In the presence of
sympathetic blockade, levels of mRNA encoding -MHC
(Figure 5, C) were significantly 6-fold lower than those of
ICP animals and were one half those of naive levels at 1, 2,
and 4 hours. Similarly, ICP-CSB animals failed to show the
increase in -MHC mRNA manifested by ICP animals
(Figure 5, D), and by 4 hours, levels were significantly
lower than those in the ICP group.
Levels of mRNAs encoding adrenergic receptors. With
increased ICP, no significant difference in mRNAs encod-
ing 1- (Figure 5, E) or 1-adrenergic (Figure 5, F) recep-
tors were found at 4 hours, although 1-adrenergic receptor
was transiently decreased in the ICP-CSB group.
Figure 4. Effect of increased ICP on left ventricular myocardial histologic features. Representative light micro-
graphs of the left ventricle are shown 60 minutes after burr hole placement in sham-operated control animals
versus brain death (ICP). Increased ICP resulted in pronounced contraction band necrosis and myocytolysis. In
contrast, brain death ameliorated with CSB (ICP-CSB) abrogates these effects with sparse lesions and minimal
contraction banding. Sham-operated control animals in the presence of CSB are shown for the sake of complete-
ness. (Hematoxylin and eosin stain, original magnification 300.)
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Figure 5. Temporal profile of specific mRNA expression levels in response to CSB in concert with increased ICP.
A through M show levels of specific mRNAs (as a ratio of poly(A)RNA in that same specimen). Data are reported
as means  SEM. Time (in hours) is shown on the x axis. Time point 0 depicts steady state mRNA levels of naive
hearts. The SEM of this group is extended horizontally across the graph as a baseline reference (shaded bar).
Asterisks indicate a statistically significant difference between groups at a given time point (P < .05, analysis of
variance). Animals with increased ICP are denoted by the dashed line, and ICP-CSB animals are denoted by the
solid line. See text for description of specific mRNA levels and Table 3 for a summary of changes.
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Levels of mRNAs encoding sarcoplasmic reticulum
proteins. When the expression levels for mRNAs encoding
sarcoplasmic reticulum proteins were measured in ICP-CSB
hearts, by 4 hours, significant decreases in mRNAs encod-
ing calcium ATPase (SERCA-2a; Figure 5, G), phospho-
lamban (Figure 5, H), and the calcium release channel or
ryanodine receptor (Figure 5, I) were noted relative to the
ICP group.
Levels of mRNAs encoding immediate early genes and
cellular stress-response genes. Blots were sequentially hy-
Figure 5. Cont’d.
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bridized with c-fos (Figure 5, J), c-jun (Figure 5, K), egr-1
(Figure 5, L), and hsp70 (Figure 5, M) cDNA probes. When
mRNA levels in ICP-CSB hearts were compared with those
of the ICP group, significantly lower egr-1 (Figure 5, L) and
c-jun (Figure 5, K) mRNA levels were found at 1, 2, and 4
hours. In the ICP group each mRNA had accumulated
2-fold over time (1-4 hours), whereas levels in the ICP-CSB
group did not differ from those of the naive animals (Figure
5, K and L). mRNA levels for c-fos (Figure 5, J) and hsp70
(Figure 5, M) were not significantly different in the ICP-
CSB group compared with those of ICP and naive animals.
Discussion
Previous studies have implicated the neuromyocardial axis
in the impaired cardiac function observed in brain dead
donors.20-23 In the current study pharmacologic blockade of
sympathetic outflow blunted the early pressor response,
electrocardiographic ST-segment changes, the early (1-
minute) spike in plasma catecholamines, and myocardial
injury associated with ICP-induced brain death. Sympa-
thetic blockade also eliminated the brain death–associated
increases in expression of myocardial gene products that
govern contractility and growth, significantly lowering the
expression levels of multiple and specific mRNAs in the left
ventricle (Table 3). These decreases were noted in all tested
myofilament programs (-actins and MHCs), all of the
sarcoplasmic reticulum genes (calcium ATPase [SERCA-
2a], calcium release channel [ryanodine receptor], and phos-
pholamban), and the transcription factors c-jun and egr-1.
The novel data in these experiments are that myocardial
gene expression changes after brain death, and adrenergic
blockade interrupts those changes. Although it would be
tempting to claim that a single gene is responsible, the
interaction of myocardial genes in complex, overlapping,
and redundant signaling networks makes this possibility
unlikely. By studying a panel of genes, we hoped to shed
light on more global patterns of gene expression after brain
death.
Decreases in sympathetic activity observed in this model
of sympathetic blockade but also manifesting in brain dead
organ donors after the initial sympathetic surge are associ-
ated with significant decreases in expression of multiple and
specific myocardial gene products. Collectively, these re-
sults correlate with previous studies in which cat-
echolamines altered myocardial gene expression in models
of injury and growth. Moreover, they suggest that loss of
sympathetic tone might result in decreases in myocardial
gene expression. Whether this is a direct effect of catechol-
amine withdrawal or a decrease in cardiac afterload result-
ing from decreased contractility, vascular resistance, or pre-
load is not known. Decreased afterload has been reported in
brain injury, but contractility might be depressed as well.
Our data cannot discriminate between these hemodynamic
factors. In the unloaded myocardium, transcriptional activ-
ity of myocardial genes and expression levels of mRNAs
encoding proteins important for contractility are re-
duced.4,13,14,24,25 Moreover, specific isoforms of proteins
that are expressed recapitulate development and thereby
alter the physiologic response of the heart. Like mechanical
unloading, a decrease in either catecholamine or trophic
factors can result in deprogramming and alter ventricular
function both in adult and neonatal myocardium.26-29 In our
study of ICP, the reduction in select mRNA levels correlates
with decreased catecholamine levels, suggesting that ICP
and ICP-CSB–treated hearts might ultimately manifest sim-
ilar phenotypes as the ICP hearts move temporally further
from the catecholamine spike induced by brain death.
The relationship between myocardial dysfunction and
TABLE 3. Comparison of the effect of increased ICP with that of ICP-CSB on myocardial gene expression
mRNA group Specific mRNA
Panel
(from
Figure 5) LV ICP LV ICP-CSB
Myofilaments Myosin heavy chain  MHC A  2
 MHC B  2
 Actins Cardiac -actin C 1 2
Skeletal -actin D 1 2
Adrenergic receptors 1 adrenergic receptor E  
1 adrenergic receptor F  T 2
Sarcoplasmic reticulum proteins CaATPase (Serca 2a) G  2
Phospholamban (Plb) H  2
Ryanodine receptor (RyR) I  2
Immediate early genes c-fos J  
c-jun K  2
egr-1 L 1 2
Heat shock protein 70 hsp 70 M 1 
Specific mRNAs are evaluated as indicated. The direction of change in gene expression is depicted: 1, direction of change is increased (P  .05); 2,
direction of change is decreased (P  .05); , there is no significant change; and T, change is transient. LV, Left ventricular.
Cardiopulmonary Support and Physiology Yeh et al
1096 The Journal of Thoracic and Cardiovascular Surgery ● December 2002
CSP
phenotype is clear in more chronic conditions, such as
increased afterload or toxic exposures. Although we have
not demonstrated cause and effect in these experiments,
hemodynamic instability and alterations in myocardial gene
expression are at least associated after brain death. Both are
interrupted by blocking the adrenergic signaling cascade.
We believe that the relationship between gene expression
and myocardial dysfunction might be underappreciated in
acute settings. For instance, it seems plausible that altered
myocardial gene expression plays an important role in post-
operative settings in which preoperative myocardial dys-
function is fatally exacerbated after the shock of global
ischemia and cold cardioplegia.
In conclusion, brain death–associated increases in sym-
pathetic nervous activity initiate changes in myocardial
gene expression that might result in myocardial deprogram-
ming and ventricular remodeling. The observed late de-
creases in systemic catecholamines associated with brain
death are implicated in the suppression of myocardial gene
expression. We hypothesize that these changes in gene
expression might affect myocardial function, even after
transplantation. Although we clearly show that both excess
as well as depletion of systemic catecholamines are associ-
ated with altered myocardial gene expression and function,
our data do not preclude other neurohumoral factors altered
by ICP, such as decreases in systemic levels of insulin,30 T3
or T4,31 or antidiuretic hormone,32 as important contributing
factors that define the ultimate phenotype of donor hearts.
Although the biologic significance of altered myocardial
gene expression after ICP-induced brain death is not yet
understood, it is important to realize that catecholamine-
associated donor myocardial dysfunction might be a result
not so much of toxicity but rather of changes in myocardial
gene expression. We are currently delineating these changes
48 hours after the insult of brain death to mirror a more
typical time point when transplant physicians are faced with
deciding whether donor heart dysfunction precludes safe
transplantation.
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